{"title":"Impact-of-COVID-19 on mortality and implications for adolescent and young-adult healthcare","authors":"Yoshiyasu Takefuji","doi":"10.1016/j.hctj.2023.100015","DOIUrl":null,"url":null,"abstract":"<div><p>This paper investigates the effect of COVID-19 on mortality in the child and adolescent population of five age groups. The CDC dataset was used for calculating the number of deaths by adolescent age group from 2015 to 2020. Results showed that the older the adolescent, the stronger the effect of COVID-19 on mortality. There is no significant impact of COVID-19 on mortality of three aged groups (1–4, 5–9 and 10–14). There is a significant impact of COVID-19 on mortality of two aged groups (15–19 and 20–24). The findings indicate that effective drugs should be used for protecting them against COVID-19 and for computational ethics.</p></div>","PeriodicalId":100602,"journal":{"name":"Health Care Transitions","volume":"1 ","pages":"Article 100015"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health Care Transitions","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2949923223000156","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
This paper investigates the effect of COVID-19 on mortality in the child and adolescent population of five age groups. The CDC dataset was used for calculating the number of deaths by adolescent age group from 2015 to 2020. Results showed that the older the adolescent, the stronger the effect of COVID-19 on mortality. There is no significant impact of COVID-19 on mortality of three aged groups (1–4, 5–9 and 10–14). There is a significant impact of COVID-19 on mortality of two aged groups (15–19 and 20–24). The findings indicate that effective drugs should be used for protecting them against COVID-19 and for computational ethics.